HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 564-569

  Sakly, Nabil ^a,b   Boumiza, Radhia ^a,b   Zrour Hassen, Saoussen ^a   Hamzaoui, Amira ^a   Yahia, Salim Ben ^a   Amara, Hamida ^a   Khairallah, Moncef ^a   Mahjoub, Sylvia ^a   Bergaoui, Naceur ^a   Ghedira, Ibtissem ^b  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Ankylosing spondylitis; Behet's disease; HLA B27; HLA B51; Tunisia

Indexed keywords

HLA B27 ANTIGEN; HLA B51 ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; BEHCET DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HLA TYPING; HUMAN; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEROLOGY; TUNISIA;

EID: 69949117221     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04756.x     Document Type: Conference Paper

References (28)

1. Ghodke, Y., K. Joshi, A. Chopra & B. Patwardhan. 2005. HLA and disease. Eur. J. Epidemiol. 20: 475-488.
2. Reveille J.D. 2006. The genetic basis of ankylosing spondylitis. Curr. Opin. Rheumatol. 18: 332-341.
3. Verity, D.H., J.E. Marr, S. Ohno, et al. 1999. Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54: 213-220.
4. Braun, J. & J. Sieper. 2007. Ankylosing spondylitis. Lancet 369: 1379-1390.
5. Davis, J.C., D. Van Der Heijde, M. Dougados & J.M. Woolley. 2005. Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy. Arthritis Rheum. 53: 494-501.
6. Sims, A.M., B.P. Wordsworth & M.A. Brown. 2004. Genetic susceptibility to ankylosing spondylitis. Curr. Mol. Med. 4: 13-20.
7. Amor, B., M. Dougados & M. Mijiyawa. 1990. [Criteria of the classification of spondylarthropathies]. Rev. Rhum. Mal. Osteoartic. 57: 85-89.
8. Fussell, H., D. Nesbeth, I. Lenart, et al. 2008. Novel detection of in vivo HLA-B27 conformations correlates with ankylosing spondylitis association. Arthritis Rheum. 58: 3419-3424.
9. Ben, R.K., S. Ayed-Jendoubi, I. Sfar, et al. 2008. Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine 75: 172-175.
10. Khan, M.A., A. Mathieu, R. Sorrentino & N. Akkoc. 2007. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun. Rev. 6: 183-189.
11. Pandrea, A., A. Rudinskaya, B. Klein & T. Krebs. 2007. What does it take to diagnose Behcet disease? J. Clin. Rheumatol. 13: 31-34.
12. Ling, E., G. Shubinsky & J. Press. 2007. Increased proportion of CD3+CD4-CD8-double-negative T cells in peripheral blood of children with Behcet's disease. Autoimmun. Rev. 6: 237-240.
13. Kurien, B.T. & R.H. Scofield. 2008. Autoimmunity and oxidatively modified autoantigens. Autoimmun. Rev. 7: 567-573.
14. Atalay, A., S. Yildiz-Demirtepe, S. Tatlipinar, et al. 2008. HLA-B51 gene and its expression in associ ation with Behcet's disease in Denizli Province of Turkey. Mol. Biol. Rep. 35: 345-349.
15. Amoura, Z., M. Guillaume, S. Caillat-Zucman, et al. 2006. [Pathophysiology of Behcet's disease]. Rev. Med. Interne 27: 843-853.
16. International Study Group for Behçet's Disease. 1990. Criteria for diagnosis of Behçet's disease. Lancet 335: 1078-1080.
17. Mathieu, A., A. Cauli, M.T. Fiorillo & R. Sorrentino. 2008. HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis. Autoimmun. Rev. 7: 398-403.
18. Ayed, K., S. Ayed-Jendoubi, I. Sfar, et al. 2004. HLA class-I and HLA class-II phenotypic, gene and hap-lotypic frequencies in Tunisians by using molecular typing data. Tissue Antigens 64: 520-532.
19. Hajjej, A., H. Kaabi, M.H. Sellami, et al. 2006. The contribution of HLA class I and II alleles and haplo-types to the investigation of the evolutionary history of Tunisians. Tissue Antigens 68: 153-162.
20. Hajjej, A., S. Hmida, H. Kaabi, et al. 2006. HLA genes in Southern Tunisians (Ghannouch area) and their relationship with other Mediterraneans. Eur. J. Med. Genet. 49: 43-56.
21. Hmida, S., A. Gauthier, A. Dridi, et al. 1995. HLA class II gene polymorphism in Tunisians. Tissue Antigens 45: 63-68.
22. Khan, M.A. 1995. HLA-B27 and its subtypes in world populations. Curr. Opin. Rheumatol. 7: 263-269.
23. Gunal, E.K., F.O. Sarvan, S. Kamali, et al. 2008. Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Joint Bone Spine 75: 299-302.
24. Makni, H., N. Lahiani-Mahfoudh, S. Baklouti, et al. 1997. Study of the HLA-B27/ankyloslng spondylltls association about 34 cases [abstract]. Immunol. Lett. 56: 167.
25. Kahn, V., M. Bechac, V. Dehlinger, et al. 2008. Etude épidémiologique d'une population de patients at-teints de spondylarthrite dans le centre hospitalier universitaire de Fort-de-France [abstract]. Revue du Rhumatisme 75: 979.
26. Brandt, H.C., I. Spiller, I.H. Song, et al. 2007. Performance of referral recommendations in patients with chronic back pain and suspected axial spondy-loarthritis. Ann. Rheum. Dis. 66: 1479-1484.
27. B'Chir, H.S., A. Harmel, K. Bouslama, et al. 2006. [Behcet's disease in Tunisia. Clinical study of 519 cases]. Rev. Med. Interne 27: 742-750.
28. Houman, M.H., H. Neffati, A. Braham, et al. 2007. Behcet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin. Exp. Rheuma-tol. 25: S58-S64.